Gene · 5015
Papers2,975
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,975
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant. | Stem Cell Res | 2023 | 37774637 | PubTator, text mining | PubMed |
| Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. | NPJ Regen Med | 2023 | 37773257 | PubTator, text mining | PubMed |
| TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa. | JCI Insight | 2023 | 37768732 | PubTator, text mining | PubMed |
| Severe Asthma and Biological Therapies: Now and the Future. | J Clin Med | 2023 | 37762787 | PubTator, text mining | PubMed |
| Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis. | Int J Mol Sci | 2023 | 37762215 | PubTator, text mining | PubMed |
| Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model. | PLoS One | 2023 | 37751459 | PubTator, text mining | PubMed |
| High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. | Front Oncol | 2023 | 37746264 | PubTator, text mining | PubMed |
| In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans. | Mol Ther Methods Clin Dev | 2023 | 37746244 | PubTator, text mining | PubMed |
| Editorial: Transcription regulation - Brain development and homeostasis - A finely tuned and orchestrated scenario in physiology and pathology, volume II. | Front Mol Neurosci | 2023 | 37736114 | PubTator, text mining | PubMed |
| Modeling unveils sex differences of signaling networks in mouse embryonic stem cells. | Mol Syst Biol | 2023 | 37735975 | PubTator, text mining | PubMed |
| Spatiotemporal, optogenetic control of gene expression in organoids. | Nat Methods | 2023 | 37735569 | PubTator, text mining | PubMed |
| Multi-omics approach reveals dysregulated genes during hESCs neuronal differentiation exposure to paracetamol. | iScience | 2023 | 37731623 | PubTator, text mining | PubMed |
| A lamprey neural cell type atlas illuminates the origins of the vertebrate brain. | Nat Ecol Evol | 2023 | 37710042 | PubTator, text mining | PubMed |
| Monolayer platform to generate and purify primordial germ-like cells in vitro provides insights into human germline specification. | Nat Commun | 2023 | 37709760 | PubTator, text mining | PubMed |
| Single-cell brain organoid screening identifies developmental defects in autism. | Nature | 2023 | 37704762 | PubTator, text mining | PubMed |
| Truncated vitronectin with E-cadherin enables the xeno-free derivation of human embryonic stem cells. | Sci Rep | 2023 | 37700192 | PubTator, text mining | PubMed |
| Integration of human stem cell-derived in vitro systems and mouse preclinical models identifies complex pathophysiologic mechanisms in retinal dystrophy. | Front Cell Dev Biol | 2023 | 37691820 | PubTator, text mining | PubMed |
| In Vitro Embryogenesis and Gastrulation Using Stem Cells in Mice and Humans. | Int J Mol Sci | 2023 | 37686459 | PubTator, text mining | PubMed |
| Establishing Functional Retina in a Dish: Progress and Promises of Induced Pluripotent Stem Cell-Based Retinal Neuron Differentiation. | Int J Mol Sci | 2023 | 37686457 | PubTator, text mining | PubMed |
| Complete human day 14 post-implantation embryo models from naive ES cells. | Nature | 2023 | 37673118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5015/papers?page=13